Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

September 19, 2023
Otsuka Pharmaceutical

Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
September 15, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Cooperative Agreement with Japan Association of Public Mental Health & Welfare Workers
September 14, 2023
Otsuka Foods

Otsuka Foods to Launch MATCH Vitamin Mikan 500ml PET Bottle New MATCH Carbonated Vitamin Drink Flavor Available Starting October 2
September 8, 2023
Otsuka Pharmaceutical

Otsuka collaborates with Shape to develop novel AAV gene therapies for ocular diseases
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Lundbeck Announce Topline Results from Two Phase 3 Trials of Brexpiprazole as Combination Therapy
September 1, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Mindset Pharma - Strengthens pipeline in the area of psychiatric and neurological disorders -
August 30, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical Announces the Launch of FGFR Inhibitor LYTGOBI® Tablets 4mg in Japan
August 25, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical and Phost’in Therapeutics Announce an Option and License Agreement on the First-in-Class GnT-V Inhibitor PhOx430
August 25, 2023
Otsuka Foods

Otsuka Foods to Revise Price of CRYSTAL GEYSER Product New Price to Take Effect with Deliveries as of October 1, 2023
August 23, 2023
Otsuka Medical Devices

Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
August 14, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Participates in Summer Events in Tokushima, Japan -EXCITING SUMMER in WAJIKI and ORONAMIN C DRINK PRESENTS Awa Odori Sound Festival-
August 8, 2023
Otsuka Pharmaceutical

Astex Expands Drug Discovery Collaboration With MSD
August 8, 2023
Otsuka Pharmaceutical

POCARI SWEAT X TOKUSHIMA VORTIS Football Dream Project Phase 3 Otsuka Pharmaceutical and Tokushima Vortis collaborate in exchange program for junior football players in Cambodia
August 7, 2023
Taiho Pharmaceutical

REZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
August 3, 2023
Taiho Pharmaceutical

FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC)
August 3, 2023
Otsuka Foods

Otsuka Foods to Launch a Bittersweet Mild Curry for Adults from the Bon Curry Brand, Celebrating Its 55th Anniversary! “Bon Curry GOLD Hojun Demi Curry Shifuku-no-Amakuchi” In Stores from August 28, 2023
August 1, 2023
Taiho Pharmaceutical

European Commission Approves LONSURF® (Trifluridine/tipiracil) in Combination With Bevacizumab in 3rd Line Refractory Metastatic Colorectal Cancer (mCRC)
July 31, 2023
Otsuka Pharmaceutical

Launch of TCRP NEXT, a New Collaboration Aiming to Promote Total Conditioning - Enhancing sustainable international competitiveness and transitioning from high performance to life performance -
July 31, 2023
Otsuka Pharmaceutical

Sumitomo Pharma and Otsuka Announce Topline Results from Phase 3 DIAMOND 1 and DIAMOND 2 Clinical Studies Evaluating Ulotaront in Schizophrenia
July 27, 2023
Otsuka Pharmaceutical

Tokushima Prefecture Signs First Resource Circulation Agreement with Otsuka Pharmaceutical - Promotion of Horizontal PET Bottle Recycling Initiatives -
July 27, 2023
Otsuka Holdings

Otsuka Holdings Selected as a Constituent of ESG Investment Indexes: FTSE4Good Index Series, FTSE Blossom Japan Index, and FTSE Blossom Japan Sector Relative Index
July 24, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Cooperative Agreement with Ministry of the Environment
July 24, 2023
Otsuka Holdings

Otsuka Group Completes Construction of Energy Management Building ーAdvancing efficiency of group-wide integrated energy management—
July 5, 2023
Taiho Pharmaceutical

European Commission Grants Conditional Marketing Authorization for Taiho’s LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma
July 5, 2023
Otsuka Foods

Otsuka Foods to Launch Three New Garlic/Spicy Curry Products from the Bon Curry Brand, Celebrating Its 55th Anniversary! “Bon Curry GOLD Umakara Ninniku Hot” “Bon Curry NEO Kogashi Ninniku Yamitsuki Spicy Hot” “Bon Curry NEO Spicy Atohiku Karasa Very Hot”
July 3, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical to Provide Matching Funds to Select Crowdfunded Projects Addressing Issues in the Field of Oncology The Third "Taiho Smile Support"
June 28, 2023
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory receives the Asia-Pacific Gel Immersion Endoscopy New Product Innovation Award of the 2023 Best Practice Award from Frost & Sullivan
June 27, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical announces positive results of phase III trial in Japan showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole
June 26, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical Obtains Approval in Japan to Manufacture and Market FGFR Inhibitor LYTGOBI ® Tablets 4mg for Unresectable Biliary Tract Cancer Harboring FGFR2 Gene Fusions That Has Progressed After Chemotherapy
June 26, 2023
Taiho Pharmaceutical

CHMP Issues Positive Opinion for Trifluridine/tipiracil (LONSURF®) in Combination With Bevacizumab in 3rd Line Refractory Metastatic Colorectal Cancer (mCRC)